This antibody is intended for in vitro diagnostic use.
Ventana Medical Systems’ CONFIRM® anti-Tyrosinase (T311) Mouse Monoclonal Primary Antibody is designed to qualitatively detect the presence of tyrosinase expressing cells via light microscopy in formalin-fixed, paraffin-embedded tissue on a Ventana automated slide stainer. Positive results aid in the classification of melanoma. The clinical interpretation of any staining, or the absence of staining, must be complemented by morphological studies and evaluation of proper controls. Evaluation must be made by a qualified pathologist within the context of the patient’s clinical history and other diagnostic tests.